UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000021209 |
|---|---|
| Receipt number | R000024455 |
| Scientific Title | A phase II trial of tri-week cycle TS-1+L-OHP+Trastuzumab combination therapy for HER2 positive advanced or recurrent gastric cancer |
| Date of disclosure of the study information | 2016/03/01 |
| Last modified on | 2018/02/25 10:07:25 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/02/25 22:01:49 | ||
| 2 | Update | 2016/03/03 08:24:07 | Recruitment status |
|
| 3 | Update | 2016/03/09 14:08:36 | Primary outcomes |
|
| 4 | Update | 2016/08/31 04:59:04 | Name of primary person or sponsor Organization Organization |
|
| 5 | Update | 2018/02/25 10:04:10 | Last name of lead principal investigator Last name of lead principal investigator Organization Organization Last name of contact person Last name of contact person Organization Organization Name of person sending information Name of person sending information Organization Organization Institute Institute Organization Organization1 |
|
| 6 | Update | 2018/02/25 10:07:25 | Email |
